Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
- 1 October 2015
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 26 (5) , 587-593
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactionsNature, 2012
- The composition and signaling of the IL-35 receptor are unconventionalNature Immunology, 2012
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10Immunology, 2011
- IL-35-mediated induction of a potent regulatory T cell populationNature Immunology, 2010
- Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 ReceptorJournal of Virology, 2009
- Historical insights into cytokinesEuropean Journal of Immunology, 2007
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003